Expertise in
16
conditions

Hiroyuki A. Watanabe

Kyoto, JP 
Expertise in
16
conditions
Kyoto, JP 
OverviewLocationsClinical Research

Overview

Hiroyuki Watanabe practices in Kyoto, Japan. Mr. Watanabe is highly rated in 16 conditions, according to our data. His top areas of expertise are Heart Tumor, SVC Obstruction, Primary Progressive Aphasia, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 600 peer reviewed articles. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Kyoto, 6068501, Japan
Other Locations
Tokyo, Japan
Akita, Japan
Yayoi, 1138657, Japan
Sagamihara, Japan
Chikushino-shi, 8180072, Japan
Obihiro, 0808555, Japan
Kochi, Japan
Okazaki, Japan
Urayasu, Japan
Minato, Japan
Nagoya, 4500002, Japan
Fukuoka, Japan
Machida, Japan
Kurashiki, Japan
Hondo, 0108543, Japan
Sapporo, Japan
Kasuga, 8160864, Japan
Chiba, Japan
Sendai, Japan
Japan
Osaka, Japan
Kanagawa, Japan
Kimura, 2600004, Japan
Shizuoka, Japan
Yokohama, Japan
Narita, 2868523, Japan
Katsura, 6158510, Japan
Suita, Japan
Higashiku, 8128582, Japan
Higashi, 8128582, Japan
Head And Neck Surgery, Kofu, Japan
Chuo, 2608670, Japan
Asahikawa, 0788510, Japan
Fujisawa, 2518555, Japan
Ushijima, 2588577, Japan
Nogi, 3290114, Japan
Department Of Otolaryngology Head And Neck Surgery, Yamanashi, Japan
Department Of Otolaryngology Head And Neck Surgery, 1110 Shimokato, Chuo, 4093898, Japan
Showa, Japan
Showa, Japan
Fuchu, 1830003, Japan
Nagasaki, 8528521, Japan
Iijima-kawabata, 0110948, Japan
Chuo, 1030026, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

600 Total Publications

A novel bivalent albumin binder for enhanced tumor retention of a fibroblast activation protein-targeted radioligand.
A novel bivalent albumin binder for enhanced tumor retention of a fibroblast activation protein-targeted radioligand.
Journal: Chemical communications (Cambridge, England)
Published: November 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Watanabe's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 105 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile